Sinopharm Group Co. Ltd.
SHTDF · OTC
6/30/2025 | 12/31/2024 | 6/30/2024 | 12/31/2023 | |
|---|---|---|---|---|
| Market Cap | $48,197 | $56,578 | $61,239 | $57,957 |
| - Cash | $35,238 | $54,313 | $43,332 | $63,809 |
| + Debt | $94,902 | $76,386 | $101,055 | $73,782 |
| Enterprise Value | $107,861 | $78,650 | $118,962 | $67,930 |
| Revenue | $286,043 | $289,781 | $294,727 | $295,619 |
| % Growth | -1.3% | -1.7% | -0.3% | – |
| Gross Profit | $20,775 | $22,312 | $21,943 | $25,241 |
| % Margin | 7.3% | 7.7% | 7.4% | 8.5% |
| EBITDA | $9,934 | $10,648 | $9,527 | $13,496 |
| % Margin | 3.5% | 3.7% | 3.2% | 4.6% |
| Net Income | $3,458 | $3,346 | $3,704 | $4,949 |
| % Margin | 1.2% | 1.2% | 1.3% | 1.7% |
| EPS Diluted | 1.11 | 1.07 | 1.19 | 1.59 |
| % Growth | 3.7% | -10.1% | -25.2% | – |
| Operating Cash Flow | -$34,111 | $52,540 | -$40,994 | $60,499 |
| Capital Expenditures | -$671 | -$1,438 | -$1,023 | -$1,240 |
| Free Cash Flow | -$34,782 | $51,102 | -$42,017 | $59,259 |